Cancer Testing Market in the US 2015-2019

アメリカのがん検査市場:乳がん、大腸がん、前立腺がん

◆タイトル:Cancer Testing Market in the US 2015-2019
◆商品コード:IRTNTR7931
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年11月18日
◆ページ数:55
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:米国
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、アメリカのがん検査市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アメリカのがん検査市場規模及び予測、がん種類別分析、市場シェア、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

Covering: Market size and forecast of the cancer testing market in the US and segmentation by technique, including genetic testing and conventional testing. The report discusses the major drivers influencing market growth and the challenges faced by the vendors and the market as a whole. The top vendors evaluated in the report are Abbott Diagnostics, Agilent Technologies, Beckman Coulter, and Roche Diagnostics.

The market in the US is experiencing a lot of transformation in healthcare coverage, which have led to increased accessibility to healthcare, and thereby facilitating early diagnosis, preventive medicine, and personalized medicine. The increase in genetic testing for cancer by end-user segments such as hospitals, diagnostic laboratories, and academics and research institutes are expected to propel the growth of the market.

Technavio predicts the cancer diagnostics market in the US to grow at a steady rate, posting a CAGR of over 9% during the forecast period.
Changes in healthcare system is one of the major drivers influencing the market growth. The number of the US citizens covered under healthcare insurance has increased tremendously and today about 19 million citizens in the US have insurance coverage. Also, big companies provide healthcare insurance policies to their employees, which will support the growth of the market.

Segmentation of the cancer testing market in the US by technique
- Genetic testing
- Conventional testing

The year 2014 saw the dominance of conventional testing segment, accounting for a market share of more than 76% and this segment is predicted to remain at the top through 2019.

Both genetic testing and conventional testing techniques are used for testing various types of cancer, including breast cancer, colorectal cancer, prostate cancer, and others.

The cancer testing market in the US marks the existence of many small and medium sized vendors offering a diversified product portfolio. Large corporations are acquiring small and medium-sized manufacturers to enhance their product portfolio, which is adding to the competition.

Top vendors in this market are -
Abbott Diagnostics
Agilent Technologies
Beckman Coulter
Roche Diagnostics

Other prominent vendors included in this report are Affymetrix, Bio-Rad Laboratories, Cardinal Health, Cytyc, Fujirebio Diagnostics, Johnson & Johnson, Pathway Genomics, QIAGEN, Quest Diagnostics, Quidel, and Rosetta Genomics.

Technavios market research analysts highlight the use of mass spectrometer, an extremely sophisticated instrumentation technology, which provide accurate results with infinitesimal amounts of material and does not even require specially purified samples.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the cancer testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: US healthcare reform
Impact of US healthcare reform on cancer testing industry

PART 06: Reimbursement and coverage: an overview
Current scenario: validating diagnostic tests
Reimbursement structure in the US
Prevailing issues of reimbursement policies

PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 08: Market segmentation by technique
Breast cancer
Colorectal cancer
Prostate cancer
Other

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 15: Key vendor analysis
Abbott Diagnostics
Agilent Technologies
Beckman Coulter
Roche Diagnostics

PART 16: Appendix
List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Comparison of US healthcare infrastructure before and after reform
Exhibit 03: Reimbursement perspectives of healthcare entities
Exhibit 04: Cancer testing market in the US
Exhibit 05: Cancer testing market in the US 2014-2019 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Segmentation of cancer testing market in the US by techniques
Exhibit 08: Segmentation of cancer testing market in the US by techniques 2014
Exhibit 09: Segmentation of cancer testing market in the US by techniques 2019
Exhibit 10: Segmentation of cancer testing market in the US by cancer type techniques 2014-2019
Exhibit 11: Breast cancer testing market in the US 2014-2019 ($ billions)
Exhibit 12: Colorectal cancer testing market in the US 2014-2019 ($ billions)
Exhibit 13: Prostate cancer testing market in the US 2014-2019 ($ billions)
Exhibit 14: Other cancers testing market in the US 2014-2019 ($ billions)
Exhibit 15: Segmentation of cancer testing market in the US by cancer type 2014
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Abbott Diagnostic: Key takeaways
Exhibit 19: Agilent Technologies: Key takeaways
Exhibit 20: Beckman Coulter: Key takeaways
Exhibit 21: Roche Diagnostics: Key takeaways
Exhibit 22: Abbott Diagnostics: Key business offerings
Exhibit 23: Agilent Technologies: Business segmentation 2014 by revenue
Exhibit 24: Agilent Technologies: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 25: Agilent Technologies: Geographical segmentation by revenue 2014
Exhibit 26: Beckman Coulter: Business segmentation



【掲載企業】

Abbott Diagnostics, Agilent Technologies, Beckman Coulter, Roche Diagnostics, Affymetrix, Bio-Rad Laboratories, Cardinal Health, Cytyc, Fujirebio Diagnostics, Johnson & Johnson, Pathway Genomics, QIAGEN, Quest Diagnostics, Quidel, Rosetta Genomics.

【資料のキーワード】

がん検査、乳がん検査、大腸がん検査、前立腺がん検査、アメリカ

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[アメリカのがん検査市場:乳がん、大腸がん、前立腺がん] (Cancer Testing Market in the US 2015-2019 / IRTNTR7931)販売に関する免責事項
[アメリカのがん検査市場:乳がん、大腸がん、前立腺がん] (Cancer Testing Market in the US 2015-2019 / IRTNTR7931)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆